Why the study?
Long-term OAC is contraindicated or poorly tolerated in many AF patients due to bleeding risk or comorbidities, making percutaneous LAAC an alternative strategy.
Is percutaneous LAAC safe and effective for stroke prevention in patients with non-valvular AF and high hemorrhagic risk, and how does TE-ICE compare to standard TEE guidance?
Population
65 patients with non-valvular AF and high hemorrhagic risk
Comparison
Watchman FLX vs LAmbre devices and TEE vs TE-ICE guidance
Design
Single-center observational study
Follow-up
Three or six months
Key result
Percutaneous left atrial appendage closure achieved 100% procedural success and 98% effective closure at 3 months, with TE-ICE guidance reducing hospital length of stay by 54%.
Authors
Loading...
Supports TE-ICE-guided LAAC feasibility in high-bleeding-risk AF; leaves open need for randomized trials before practice change.
Observational (n=65)
No
Is percutaneous LAAC safe and effective for stroke prevention in patients with non-valvular AF and high hemorrhagic risk, and how does TE-ICE compare to standard TEE guidance?
Percutaneous LAAC is a safe and effective strategy for stroke prevention in AF patients with high bleeding risk, and TE-ICE guidance may further optimize outcomes by reducing hospital length of stay.
Scalcione et al. (2026) conducted an observational in Non-valvular atrial fibrillation with high hemorrhagic risk (n=65). Percutaneous left atrial appendage closure (LAAC) was evaluated on Procedural success. Percutaneous left atrial appendage closure achieved 100% procedural success and 98% effective closure at 3 months, with TE-ICE guidance reducing hospital length of stay by 54%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: